Polymerase Chain Reaction Market to Rise at a CAGR of 8.3% and Hit USD 8.14 Billion by 2026; Advent of Miniature PCR Devices Will Bode Well for Market, reports Fortune Business Insights™

Key Prominent Players Covered in the Polymerase Chain Reaction Market Research Report Are Agilent Technologies, Inc., Qiagen , F.Hoffmann-La Roche Ltd , Bio-Rad Laboratories, Inc. , Sysmex Inostics , Abbott , Thermo Fischer Scientific Inc. , Eppendorf AG and Other players


Pune, India, March 03, 2021 (GLOBE NEWSWIRE) -- The global Polymerase Chain Reaction Market size is expected to reach USD 8.14 billion by 2026, on account of the advent of digitalization and the gradual shift from traditional PCR to digital PCR for diagnostics purposes. PCR is considered the most unique and most widely referred clinical testing technique utilized in modern biology. It includes a molecular technology for the in-vitro amplification of a specific region in a DNA strand.

More information on this market is presented in a recently published report by Fortune Business Insights™ titled, “Polymerase Chain Reaction Market Size, Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026.”As per this report, the market value was USD 4.31 billion in 2018 and will rise at a CAGR of 8.3% between 2019 to 2026.


Request a Sample Copy of the Research Report: 

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/polymerase-chain-reaction-pcr-market-102528


Key Industry Developments of the Polymerase Chain Reaction Market Include:

June 2017 – CFX Maestro Software was launched by Bio-Rad Laboratories, Inc. for real-time PCR data analysis and collection.

January 2019 – A molecular diagnostics company Asuragen Inc., announced the launch of its simple detection test for Huntington’s Diseases called AmplideX PCR/CE HTT Kit.


An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


For More Information in the Analysis of Reports:

https://www.fortunebusinessinsights.com/polymerase-chain-reaction-pcr-market-102528


Government Initiatives for Increasing Awareness will Augment Growth

The increasing prevalence of infectious and genetic diseases is a significant factor in promoting the polymerase chain reaction market growth. Besides this, the rise in demand for innovative devices and the advent of miniature PCR devices are aiding in the expansion of the market. Moreover, the highly precise and direct quantification of digital PCRs is further anticipated to attract high PCR market revenue during the forecast period.

However, the high cost associated with commercial PCR assays may pose a significant hindrance to the growth of the market. This, coupled with the lack of awareness about PCR and their diagnostic benefits in underdeveloped nations, may also restrict its growth. Nevertheless, a lead analyst at Fortune Business Insights says, “Increasing initiatives taken by both government and non-governmental support organizations to spread awareness and expand product offerings by increasing awareness about the same is prognosticated to create lucrative growth opportunities in the near future.”


North America Dominating Market with Adequate Reimbursement Policies for PCR Devices

As per segmentation by region, North America earned a revenue of USD 1.72 billion in 2018 and contributed the largest polymerase chain reaction market share. Factors attributed to this dominance include the increasing prevalence and diagnosis cases of infectious diseases, the presence of adequate reimbursement policies for PCR devices, and the high number of the patient population adopting new diagnostic procedures. This is being followed by Europe, owing to the increasing incidences of different cancer types and metabolic diseases that require advanced therapies and diagnosis.

Additionally, the Asia Pacific market is likely to witness robust growth during the forecast period on account of the rise in awareness amongst the patient population about the presence of advanced PCR devices, coupled with the presence of a substantial underpenetrated market. Furthermore, the Middle East and Africa and Latin America markets are considered to be in the nascent stage and are likely to witness stable growth in the coming years. This is attributable to the increasing prevalence of genetic and infectious diseases.


Quick Buy - Polymerase Chain Reaction (PCR)Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/102528


Mergers and Acquisitions Strategies Adopted by Players will Help Gain High Revenue

The global polymerase chain reaction market has a diverse portfolio on account of the presence of both digital PCR and real-time PCR. Leading players of this market include companies such as Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd. Players are adopting strategies such as the introduction of new products, substantial investment in research and development of the same, company collaborations, mergers and acquisitions, and others for gaining the upper hand in the market competition.

List of Notable Polymerase Chain Reaction Market Manufacturers are:

  • Agilent Technologies, Inc.,
  • Qiagen
  • F.Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Sysmex Inostics
  • Abbott
  • Thermo Fischer Scientific Inc.
  • Eppendorf AG
  • Other players


Speak To Analyst :

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/polymerase-chain-reaction-pcr-market-102528


Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Chronic Disorders (Infectious diseases, Cancer)
    • Key Industry Developments – Mergers, Acquisitions, Partnerships & New Product Launch
    • Technological Advancements in PCR
    • Regulatory Scenario by Key Countries/Region
  • Global Polymerase Chain Reaction Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Standard PCR
      • Real-time PCR
      • Digital PCR
    • Market Analysis, Insights and Forecast – By Product
      • Instruments
      • Reagents & Consumables
    • Market Analysis, Insights and Forecast – By Indication
      • Infectious Diseases
      • Oncology
      • Genetic Disorders
      • Others
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals & Clinics
      • Pharmaceutical & Biotechnology Industries
      • Diagnostic Centers
      • Academic & Research Organization
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa


Toc Continue …


Get your Customized Research Report:  https://www.fortunebusinessinsights.com/enquiry/customization/polymerase-chain-reaction-pcr-market-102528


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Orthopedic Implants Market Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants; Trauma Implants, Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026

U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026

Urinary Catheter Market Share & Industry Analysis, By Product (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Surgery, and Others), By Gender (Female, Male), By End User (Hospitals, Age Care Centers, and Others) and Regional Forecast 2019-2026

Subdural Electrode Market Share & Industry Analysis, By Type (Strip, Grid, Depth, and Others) By Material (Platinum and Stainless Steel) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026

Immune Thrombocytopenia (ITP) Market Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs